Oklahoma 2026 Regular Session

Oklahoma House Bill HB2817

Introduced
2/3/25  

Caption

Health care; creating the Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager Meaningful Transparency Act of 2025; definitions; requirements; effective date.

Impact

The bill will significantly amend existing regulations pertaining to pharmacy benefits management within the state. By instituting penalties for violations of the defined cost sharing requirements, the legislation empowers the Insurance Commissioner to enforce compliance. It also emphasizes the provision of important disclosure information to relevant parties, including insurers and the Attorney General, which could lead to better oversight and monitoring of PBM practices. The regulations intend to help mitigate unnecessary costs for patients and increase competition in the drug pricing environment.

Summary

House Bill 2817, titled the 'Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager Meaningful Transparency Act of 2025', seeks to enhance transparency and fairness in the pharmaceutical sector, particularly regarding the actions of pharmacy benefits managers (PBMs). The bill establishes that an enrollee's defined cost sharing for each prescription drug must be calculated at the point of sale based on a price reduced by at least 85% of all rebates received in connection with the drug. This measure aims to ensure that consumers benefit financially from the rebates intended to lower drug prices.

Contention

Despite the potential benefits of HB2817, there are concerns surrounding the implications of increased regulation on PBMs. Proponents argue that the increased transparency will help lower drug prices for consumers, while opponents may view the regulations as an additional burden that could limit operational flexibility for PBMs. Notably, the confidentiality requirements concerning rebate information could be a topic of contention, with some expressing concerns about how these provisions might impact competition and market dynamics within the health insurance sector.

Companion Bills

OK HB2817

Carry Over Health care; creating the Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager Meaningful Transparency Act of 2025; definitions; requirements; effective date.

Previously Filed As

OK HB2817

Health care; creating the Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager Meaningful Transparency Act of 2025; definitions; requirements; effective date.

OK SB1025

Health care; creating the Oklahoma Rebate Pass-Through and Pharmacy Benefits Manager Meaningful Transparency Act of 2025; clarifying authority to take certain actions. Effective date.

OK SB161

Pharmacy benefit management; requiring pharmacy benefit managers to maintain certain fiduciary duty. Effective date.

OK SB773

Pharmacy benefit managers; modifying definitions; prohibiting certain circumstances; requiring nonpayment under providing venue for certain court proceeding; allowing Attorney General to obtain certain information. Effective date.

OK SB993

Pharmacy benefit managers; establishing requirements and limits for certain audit reports and findings. Emergency.

OK HB2048

Prescriptions; 340B Nondiscrimination Act; definitions; discriminatory actions; reimbursement; manufacturer; distributor; enforcement; Attorney General; Insurance Commissioner; violations; federal preemption; effective date.

OK SB789

Pharmacy benefit managers; permitting use of certain records without limitations of date or source for certain purposes; establishing certain reimbursement rates for certain drugs. Effective date.

OK SB741

Practice of pharmacy; allowing pharmacist to test for and initiate drug therapy for certain minor, nonchronic health conditions. Effective date.

OK HB2298

Practice of nursing; providing for independent prescriptive authority of Advanced Practice Registered Nurses who meet certain requirements; modifying various provisions of the Oklahoma Pharmacy Act, the Oklahoma Nursing Practice Act, and the Uniform Controlled Dangerous Substances Act; effective date.

OK SB1030

Prescription drug pricing; prohibiting certain action. Effective date.

Similar Bills

No similar bills found.